Abstract

Over the past two years, COVID-19 pandemic is an unprecedented health emergency. All countries have taken their own measures to mitigate the spread of the virus in the first and subsequent mini-outbreaks of infection. In view of the current situation of small outbreaks of COVID-19, guidelines on epidemic prevention should be developed specifically for reproductive medical centers. It is necessary to establish a dynamic patient assessment and management system to identify patients who need priority fertility treatment during epidemic control. Female Patients were assigned as grade A and required hospitalization in the inpatient ward after egg retrieval. Patients who underwent controlled ovarian stimulation were classified as grade B, and they can choose to be hospitalizedat home according to their own convenience. Patients undergoing frozen embryo transfer (FET) cycle or planned downregulation with gonadotropinreleasing hormone agonists were defined as grade C, who could continue the assisted reproductive technology (ART) treatment cycle with negative COVID-19 nucleic acid test and there was no fever or respiratory symptoms. This brief comment summarizes the working procedure of the reproductive medical center in the first hospital of Lanzhou University in China to minimize the probability of hospital infection and ensure the safe conduct of assisted reproductive technology therapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call